{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:56:07Z","timestamp":1790103367631,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00134-021-06502-2","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T05:02:57Z","timestamp":1631595777000},"page":"1104-1114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Critical illness in patients with hematologic malignancy: a population-based cohort study"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-3741","authenticated-orcid":false,"given":"Bruno L.","family":"Ferreyro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon C.","family":"Scales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wunsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refik","family":"Saskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhosh","family":"Thyagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laveena","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"6502_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jamaoncol.2016.3928","volume":"3","author":"JG Jurcic","year":"2017","unstructured":"Jurcic JG (2017) Highlights in hematologic malignancy treatments: leukemia, myelodysplastic syndromes, and allotransplant-new drugs on the horizon for acute myeloid leukemia. JAMA Oncol 3:299\u2013300. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3928","journal-title":"JAMA Oncol"},{"key":"6502_CR2","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/cncr.30003","volume":"122","author":"D Pulte","year":"2016","unstructured":"Pulte D, Jansen L, Castro FA, Brenner H (2016) Changes in the survival of older patients with hematologic malignancies in the early 21st century. Cancer 122:2031\u20132040. https:\/\/doi.org\/10.1002\/cncr.30003","journal-title":"Cancer"},{"key":"6502_CR3","doi-asserted-by":"publisher","first-page":"157570","DOI":"10.1155\/2015\/157570","volume":"2015","author":"H Ma","year":"2015","unstructured":"Ma H, Mallampati S, An G, Wang J (2015) Targeted therapy in hematological malignancies: from basic research to clinical practice. Biomed Res Int 2015:157570. https:\/\/doi.org\/10.1155\/2015\/157570","journal-title":"Biomed Res Int"},{"key":"6502_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1200\/JCO.20.03106","volume":"39","author":"C Craddock","year":"2021","unstructured":"Craddock C, Friedberg JW (2021) Immunotherapy for hematologic malignancies. J Clin Oncol 39:343\u2013345. https:\/\/doi.org\/10.1200\/JCO.20.03106","journal-title":"J Clin Oncol"},{"key":"6502_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1470-2045(14)70282-7","volume":"15","author":"M Sant","year":"2014","unstructured":"Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadie M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R, Group E-W (2014) Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol 15:931\u2013942. https:\/\/doi.org\/10.1016\/S1470-2045(14)70282-7","journal-title":"Lancet Oncol"},{"key":"6502_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41408-020-0323-4","volume":"10","author":"D Pulte","year":"2020","unstructured":"Pulte D, Jansen L, Brenner H (2020) Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood Cancer J 10:56. https:\/\/doi.org\/10.1038\/s41408-020-0323-4","journal-title":"Blood Cancer J"},{"key":"6502_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00134-014-3373-x","volume":"40","author":"M van Vliet","year":"2014","unstructured":"van Vliet M, Verburg IW, van den Boogaard M, de Keizer NF, Peek N, Blijlevens NM, Pickkers P (2014) Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. Intensive Care Med 40:1275\u20131284. https:\/\/doi.org\/10.1007\/s00134-014-3373-x","journal-title":"Intensive Care Med"},{"key":"6502_CR8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00134-017-4884-z","volume":"43","author":"E Azoulay","year":"2017","unstructured":"Azoulay E, Schellongowski P, Darmon M, Bauer PR, Benoit D, Depuydt P, Divatia JV, Lemiale V, van Vliet M, Meert A-P, Mokart D, Pastores SM, Perner A, P\u00e8ne F, Pickkers P, Puxty KA, Vincent F, Salluh J, Soubani AO, Antonelli M, Staudinger T, von Bergwelt-Baildon M, Soares M (2017) The Intensive Care Medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med 43:1366\u20131382. https:\/\/doi.org\/10.1007\/s00134-017-4884-z","journal-title":"Intensive Care Med"},{"key":"6502_CR9","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","volume":"31","author":"E Azoulay","year":"2013","unstructured":"Azoulay E, Mokart D, P\u00e8ne F, Lambert J, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne L-M, Rabbat A, Lebert C, Perez P, Chaize M, Renault A, Meert A-P, Benoit D, Hamidfar R, Jourdain M, Darmon M, Schlemmer B, Chevret S, Lemiale V (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from france and belgium\u2014a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study. J Clin Oncol 31:2810\u20132818. https:\/\/doi.org\/10.1200\/JCO.2012.47.2365","journal-title":"J Clin Oncol"},{"key":"6502_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.blre.2015.04.002","volume":"29","author":"E Azoulay","year":"2015","unstructured":"Azoulay E, P\u00e8ne F, Darmon M, Lenglin\u00e9 E, Benoit D, Soares M, Vincent F, Bruneel F, Perez P, Lemiale V, Mokart D, de Recherche Respiratoire en R\u00e9animation Onco-H\u00e9matologique Grrr-OH G (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29:359\u2013367. https:\/\/doi.org\/10.1016\/j.blre.2015.04.002","journal-title":"Blood Rev"},{"key":"6502_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00134-016-4224-8","volume":"42","author":"E Azoulay","year":"2016","unstructured":"Azoulay E, Soares M, Benoit D (2016) Focus on immunocompromised patients. Intensive Care Med 42:463\u2013465. https:\/\/doi.org\/10.1007\/s00134-016-4224-8","journal-title":"Intensive Care Med"},{"key":"6502_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1179\/1607845414Y.0000000206","volume":"20","author":"M Grgi\u0107 Medi\u0107","year":"2015","unstructured":"Grgi\u0107 Medi\u0107 M, Gornik I, Ga\u0161parovi\u0107 V (2015) Hematologic malignancies in the medical intensive care unit\u2013outcomes and prognostic factors. Hematology 20:247\u2013253. https:\/\/doi.org\/10.1179\/1607845414Y.0000000206","journal-title":"Hematology"},{"key":"6502_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamaoncol.2016.4858","volume":"3","author":"AB Halpern","year":"2017","unstructured":"Halpern AB, Culakova E, Walter RB, Lyman GH (2017) Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit. JAMA Oncol 3:374\u2013378. https:\/\/doi.org\/10.1001\/jamaoncol.2016.4858","journal-title":"JAMA Oncol"},{"key":"6502_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.leukres.2018.08.004","volume":"73","author":"BL Ferreyro","year":"2018","unstructured":"Ferreyro BL, Munshi L, Detsky ME, Minden MD, Cheung A, Burry L, Lee C (2018) Acute promyelocytic leukemia in the intensive care unit: a retrospective analysis. Leuk Res 73:41\u201343. https:\/\/doi.org\/10.1016\/j.leukres.2018.08.004","journal-title":"Leuk Res"},{"key":"6502_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00134-014-3433-2","volume":"40","author":"D Mokart","year":"2014","unstructured":"Mokart D, Salluh JIF, Staudinger T (2014) Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 40:1573\u20131575. https:\/\/doi.org\/10.1007\/s00134-014-3433-2","journal-title":"Intensive Care Med"},{"key":"6502_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05653-7","author":"M Darmon","year":"2019","unstructured":"Darmon M, Bourmaud A, Georges Q, Soares M, Jeon K, Oeyen S, Rhee CK, Gruber P, Ostermann M, Hill QA, Depuydt P, Ferra C, Toffart AC, Schellongowski P, Muller A, Lemiale V, Mokart D, Azoulay E (2019) Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-019-05653-7","journal-title":"Intensive Care Med"},{"key":"6502_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00134-020-06184-2","volume":"47","author":"FG Zampieri","year":"2021","unstructured":"Zampieri FG, Romano TG, Salluh JIF, Taniguchi LU, Mendes PV, Nassar AP Jr, Costa R, Viana WN, Maia MO, Lima MFA, Cappi SB, Carvalho AGR, De Marco FVC, Santino MS, Perecmanis E, Miranda FG, Ramos GV, Silva AR, Hoff PM, Bozza FA, Soares M (2021) Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study. Intensive Care Med 47:170\u2013179. https:\/\/doi.org\/10.1007\/s00134-020-06184-2","journal-title":"Intensive Care Med"},{"key":"6502_CR18","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00134-018-5347-x","volume":"44","author":"C Lueck","year":"2018","unstructured":"Lueck C, Stadler M, Koenecke C, Hoeper MM, Dammann E, Schneider A, Kielstein JT, Ganser A, Eder M, Beutel G (2018) Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med 44:1483\u20131492. https:\/\/doi.org\/10.1007\/s00134-018-5347-x","journal-title":"Intensive Care Med"},{"key":"6502_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/CCM.0000000000003717","volume":"47","author":"L Biard","year":"2019","unstructured":"Biard L, Darmon M, Lemiale V, Mokart D, Chevret S, Azoulay E, Resche-Rigon M (2019) Center effects in hospital mortality of critically ill patients with hematologic malignancies. Crit Care Med 47:809\u2013816. https:\/\/doi.org\/10.1097\/CCM.0000000000003717","journal-title":"Crit Care Med"},{"key":"6502_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/CCM.0B013E318165314B","volume":"36","author":"F P\u00e8ne","year":"2008","unstructured":"P\u00e8ne F, Percheron S, Lemiale V, Viallon V, Claessens Y-E, Marqu\u00e9 S, Charpentier J, Angus DC, Cariou A, Chiche J-D, Mira J-P (2008) Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 36:690\u2013696. https:\/\/doi.org\/10.1097\/CCM.0B013E318165314B","journal-title":"Crit Care Med"},{"key":"6502_CR21","doi-asserted-by":"publisher","first-page":"21145","DOI":"10.1038\/s41598-020-78114-7","volume":"10","author":"A Vijenthira","year":"2020","unstructured":"Vijenthira A, Chiu N, Jacobson D, Freedman Z, Cheung MC, Goddard S, Fowler R, Buckstein R (2020) Predictors of intensive care unit admission in patients with hematologic malignancy. Sci Rep 10:21145. https:\/\/doi.org\/10.1038\/s41598-020-78114-7","journal-title":"Sci Rep"},{"key":"6502_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10654-013-9873-0","volume":"29","author":"LC Thygesen","year":"2014","unstructured":"Thygesen LC, Ersboll AK (2014) When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol 29:551\u2013558. https:\/\/doi.org\/10.1007\/s10654-013-9873-0","journal-title":"Eur J Epidemiol"},{"key":"6502_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/jech-2013-202744","volume":"68","author":"N Gavrielov-Yusim","year":"2014","unstructured":"Gavrielov-Yusim N, Friger M (2014) Use of administrative medical databases in population-based research. J Epidemiol Community Health 68:283\u2013287. https:\/\/doi.org\/10.1136\/jech-2013-202744","journal-title":"J Epidemiol Community Health"},{"key":"6502_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jcrc.2005.08.002","volume":"20","author":"H Wunsch","year":"2005","unstructured":"Wunsch H, Harrison DA, Rowan K (2005) Health services research in critical care using administrative data. J Crit Care 20:264\u2013269. https:\/\/doi.org\/10.1016\/j.jcrc.2005.08.002","journal-title":"J Crit Care"},{"key":"6502_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2105\/ajph.90.5.695","volume":"90","author":"JN Izquierdo","year":"2000","unstructured":"Izquierdo JN, Schoenbach VJ (2000) The potential and limitations of data from population-based state cancer registries. Am J Public Health 90:695\u2013698. https:\/\/doi.org\/10.2105\/ajph.90.5.695","journal-title":"Am J Public Health"},{"issue":"5","key":"6502_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0895-4356(88)90052-2","volume":"14.41","author":"SC Robles","year":"1988","unstructured":"Robles SC, Marrett LD, Clarke EA et al (1988) An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 14.41(5):495\u2013501","journal-title":"J Clin Epidemiol"},{"key":"6502_CR27","first-page":"246","volume-title":"Cancer registration in Ontario: a computer approach","author":"E Clarke","year":"1991","unstructured":"Clarke E, Marrett L, Kreiger N (1991) Cancer registration in Ontario: a computer approach. Cancer registration principlesand methods. IARC Publications, Lyon, pp 246\u2013257"},{"key":"6502_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MLR.0b013e318245a754","volume":"50","author":"A Garland","year":"2012","unstructured":"Garland A, Yogendran M, Olafson K, Scales DC, McGowan K-L, Fransoo R (2012) The accuracy of administrative data for identifying the presence and timing of admission to intensive care units in a Canadian province. Med Care 50:e1-6. https:\/\/doi.org\/10.1097\/MLR.0b013e318245a754","journal-title":"Med Care"},{"key":"6502_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jclinepi.2005.11.015","volume":"59","author":"DC Scales","year":"2006","unstructured":"Scales DC, Guan J, Martin CM, Redelmeier DA (2006) Administrative data accurately identified intensive care unit admissions in Ontario. J Clin Epidemiol 59:802\u2013807. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.11.015","journal-title":"J Clin Epidemiol"},{"key":"6502_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","volume":"38","author":"PC Austin","year":"2009","unstructured":"Austin PC (2009) Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput 38:1228\u20131234. https:\/\/doi.org\/10.1080\/03610910902859574","journal-title":"Commun Stat Simul Comput"},{"key":"6502_CR31","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36:4391\u20134400. https:\/\/doi.org\/10.1002\/sim.7501","journal-title":"Stat Med"},{"key":"6502_CR32","doi-asserted-by":"publisher","first-page":"E306","DOI":"10.9778\/cmajo.20180097","volume":"7","author":"AD Hill","year":"2019","unstructured":"Hill AD, Stukel TA, Fu L, Scales DC, Laupacis A, Rubenfeld GD, Wunsch H, Downar J, Rockwood K, Heyland DK, Sinha SK, Zimmermann C, Gandhi S, Myers J, Ross HJ, Kozak JF, Berry S, Dev SP, La Delfa I, Fowler RA (2019) Trends in site of death and health care utilization at the end of life: a population-based cohort study. CMAJ Open 7:E306\u2013E315. https:\/\/doi.org\/10.9778\/cmajo.20180097","journal-title":"CMAJ Open"},{"key":"6502_CR33","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/jama.2017.14418","volume":"318","author":"CJ Yarnell","year":"2017","unstructured":"Yarnell CJ, Fu L, Manuel D, Tanuseputro P, Stukel T, Pinto R, Scales DC, Laupacis A, Fowler RA (2017) Association between immigrant status and end-of-life care in Ontario, Canada. JAMA 318:1479\u20131488. https:\/\/doi.org\/10.1001\/jama.2017.14418","journal-title":"JAMA"},{"key":"6502_CR34","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1097\/00003246-200005000-00011","volume":"28","author":"T Staudinger","year":"2000","unstructured":"Staudinger T, Stoiser B, M\u00fcllner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322\u20131328","journal-title":"Crit Care Med"},{"key":"6502_CR35","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202006-678OC","author":"J Spring","year":"2021","unstructured":"Spring J, McKinlay J, Puxty K, Metaxa V, Detsky M, Mehta S, Thyagu S, McGuigan K, Munshi L (2021) Perspectives on advance care planning for patients with hematologic malignancies: an international clinician questionnaire. Ann Am Thorac Soc. https:\/\/doi.org\/10.1513\/AnnalsATS.202006-678OC","journal-title":"Ann Am Thorac Soc"},{"key":"6502_CR36","doi-asserted-by":"publisher","first-page":"igx012","DOI":"10.1093\/geroni\/igx012","volume":"1","author":"D Carr","year":"2017","unstructured":"Carr D, Luth EA (2017) Advance care planning: contemporary issues and future directions. Innov Aging 1:igx012. https:\/\/doi.org\/10.1093\/geroni\/igx012","journal-title":"Innov Aging"},{"key":"6502_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00134-017-4884-z","volume":"43","author":"E Azoulay","year":"2017","unstructured":"Azoulay E, Schellongowski P, Darmon M, Bauer PR, Benoit D, Depuydt P, Divatia JV, Lemiale V, Vliet M, Meert A-P, Mokart D, Pastores SM, Perner A, P\u00e8ne F, Pickkers P, Puxty KA, Vincent F, Salluh J, Soubani AO, Antonelli M, Staudinger T, Bergwelt-Baildon M, Soares M (2017) The Intensive Care Medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med 43:1\u201317. https:\/\/doi.org\/10.1007\/s00134-017-4884-z","journal-title":"Intensive Care Med"},{"key":"6502_CR38","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s00134-014-3433-2","volume":"40","author":"D Mokart","year":"2014","unstructured":"Mokart D, Pastores SM, Darmon M (2014) Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 40:1570\u20131572. https:\/\/doi.org\/10.1007\/s00134-014-3433-2","journal-title":"Intensive Care Med"},{"key":"6502_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13054-016-1248-y","volume":"20","author":"AD Hill","year":"2016","unstructured":"Hill AD, Fowler RA, Pinto R, Herridge MS, Cuthbertson BH, Scales DC (2016) Long-term outcomes and healthcare utilization following critical illness\u2013a population-based study. Crit Care 20:76. https:\/\/doi.org\/10.1186\/s13054-016-1248-y","journal-title":"Crit Care"},{"key":"6502_CR40","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1056\/NEJMsa012528","volume":"346","author":"TR Fried","year":"2002","unstructured":"Fried TR, Bradley EH, Towle VR, Allore H (2002) Understanding the treatment preferences of seriously ill patients. N Engl J Med 346:1061\u20131066. https:\/\/doi.org\/10.1056\/NEJMsa012528","journal-title":"N Engl J Med"},{"key":"6502_CR41","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/01.ccm.0000157752.26180.f1","volume":"33","author":"M Garrouste-Orgeas","year":"2005","unstructured":"Garrouste-Orgeas M, Montuclard L, Timsit JF, Reignier J, Desmettre T, Karoubi P, Moreau D, Montesino L, Duguet A, Boussat S, Ede C, Monseau Y, Paule T, Misset B, Carlet J, French ASG (2005) Predictors of intensive care unit refusal in French intensive care units: a multiple-center study. Crit Care Med 33:750\u2013755. https:\/\/doi.org\/10.1097\/01.ccm.0000157752.26180.f1","journal-title":"Crit Care Med"},{"key":"6502_CR42","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00134-020-06193-1","volume":"46","author":"E Azoulay","year":"2020","unstructured":"Azoulay E, Darmon M, Valade S (2020) Acute life-threatening toxicity from CAR T-cell therapy. Intensive Care Med 46:1723\u20131726. https:\/\/doi.org\/10.1007\/s00134-020-06193-1","journal-title":"Intensive Care Med"},{"key":"6502_CR43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1200\/JCO.20.01749","volume":"39","author":"KV Komanduri","year":"2021","unstructured":"Komanduri KV (2021) Chimeric antigen receptor T-cell therapy in the management of relapsed non-Hodgkin lymphoma. J Clin Oncol 39:476\u2013486. https:\/\/doi.org\/10.1200\/JCO.20.01749","journal-title":"J Clin Oncol"},{"key":"6502_CR44","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1200\/JCO.20.01616","volume":"39","author":"PM Reagan","year":"2021","unstructured":"Reagan PM, Neelapu SS (2021) How I manage: pathophysiology and management of toxicity of chimeric antigen receptor T-cell therapies. J Clin Oncol 39:456\u2013466. https:\/\/doi.org\/10.1200\/JCO.20.01616","journal-title":"J Clin Oncol"},{"key":"6502_CR45","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1016\/S2352-3026(21)00060-0","volume":"8","author":"E Azoulay","year":"2021","unstructured":"Azoulay E, Castro P, Maamar A, Metaxa V, de Moraes AG, Voigt L, Wallet F, Klouche K, Picard M, Moreau AS, Van De Louw A, Seguin A, Mokart D, Chawla S, Leroy J, Boll B, Issa N, Levy B, Hemelaar P, Fernandez S, Munshi L, Bauer P, Schellongowski P, Joannidis M, Moreno-Gonzalez G, Galstian G, Darmon M, Valade S, Ii N (2021) Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study. Lancet Haematol 8:e355\u2013e364. https:\/\/doi.org\/10.1016\/S2352-3026(21)00060-0","journal-title":"Lancet Haematol"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-021-06502-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-021-06502-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-021-06502-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T17:36:52Z","timestamp":1633109812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-021-06502-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["6502"],"URL":"https:\/\/doi.org\/10.1007\/s00134-021-06502-2","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"14 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest relevant to the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"ICES is an independent, non-profit research institute whose legal status under Ontario\u2019s health information privacy law allows it to collect and analyze health-care and demographic data, without consent, for health system evaluation and improvement. The use of the data in this project is authorized under section 45 of Ontario\u2019s Personal Health Information Protection Act (PHIPA) and does not require review by a Research Ethics Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable (see \u201cEthical approval\u201d).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}